View Item 

Show simple item record

RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double‐blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics
dc.contributor.authorSilbergleit, Roberten_US
dc.contributor.authorLowenstein, Daniel H.en_US
dc.contributor.authorDurkalski, Valerieen_US
dc.contributor.authorConwit, Robinen_US
dc.date.accessioned2011-11-10T15:31:46Z
dc.date.available2012-12-03T21:17:29Zen_US
dc.date.issued2011-10en_US
dc.identifier.citationSilbergleit, Robert; Lowenstein, Daniel; Durkalski, Valerie; Conwit, Robin (2011). "RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double‐blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics." Epilepsia 52. <http://hdl.handle.net/2027.42/86836>en_US
dc.identifier.issn0013-9580en_US
dc.identifier.issn1528-1167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/86836
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherBinary Outcomeen_US
dc.subject.otherIntravenousen_US
dc.subject.otherIntramuscularen_US
dc.subject.otherLorazepamen_US
dc.subject.otherMidazolamen_US
dc.subject.otherPlaceboen_US
dc.subject.otherSeizure Terminationen_US
dc.titleRAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double‐blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedicsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Emergency Medicine, University of Michigan Health System, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Neurology, University of California, San Francisco, California, U.S.A.en_US
dc.contributor.affiliationotherDivision of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, U.S.A.en_US
dc.contributor.affiliationotherDivision of Extramural Research, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, U.S.A.en_US
dc.identifier.pmid21967361en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/86836/1/j.1528-1167.2011.03235.x.pdf
dc.identifier.doi10.1111/j.1528-1167.2011.03235.xen_US
dc.identifier.sourceEpilepsiaen_US
dc.identifier.citedreferenceAlldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O’Neil N, Neuhaus JM, Segal MR, Lowenstein DH. ( 2001 ) A comparison of lorazepam, diazepam, and placebo for the treatment of out‐of‐hospital status epilepticus. N Engl J Med 345: 631 – 637.en_US
dc.identifier.citedreferenceDunnett CW, Gent M. ( 1977 ) Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. Biometrics 33: 593 – 602.en_US
dc.identifier.citedreferenceFDA. ( 2005 ) Exception from informed consent requirements for emergency research. Code of Federal Regulations, U.S. Government Printing Office via GPO Access, 2005. (Accessed 21CFR50.24, at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24.)en_US
dc.identifier.citedreferenceWarden CR, Frederick C. ( 2006 ) Midazolam and diazepam for pediatric seizures in the prehospital setting. Prehosp Emerg Care 10: 463 – 467.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1528-1167.2011.03235.x.pdf
Size:
88.50KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.